NCT02281045View on ClinicalTrials.gov

CITrate and Evodial for Effective Dialysis (CITED) Study

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Chronic Kidney Disease
Interventions
DEVICE

EVODIAL dialyzer and Selectbag citrate

Evodial is a trademark of Hospal-Gambro.

DEVICE

Regional citrate anticoagulation

Regional citrate anticoagulation is performed according to local practice, using a calcium-containing dialysate

Trial Locations (2)

3000

Universitaire Ziekenhuizen Leuven, Leuven

University Hospitals Leuven, Leuven

All Listed Sponsors
lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT02281045 - CITrate and Evodial for Effective Dialysis (CITED) Study | Biotech Hunter | Biotech Hunter